Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Dives Into Inflammasome Pool With IFM Tre Purchase

Apr 01 2019

• By Kevin Grogan

Splash — Novartis hopes to make a splash in NLRP3 • Source: Shutterstock

Related Content

Inflammasome's Time Has Come, Says Ex-GSK NodThera Chief After £28m Financing

Jun 25 2018

An Inflammatory Deal: Bristol Commits Up To $2.3bn To Buy IFM Therapeutics

Aug 04 2017

Related Companies

Novartis AG

IFM Therapeutics

Bristol Myers Squibb Company

Roche Holding AG

Inflazome Ltd.

NodThera Limited

Additional Topics

M & A Deals Commercial Research & Development Inflammation BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window